Opening Summary The capital markets saw a significant rebound in 2024, improving markedly from the challenges of 2023. This positive shift was driven by key economic trends that created a more favorable investment environment. Global economic resilience played a crucial role, as inflationary pressures eased and the Federal Reserve initiated a series of three interest […]
Author: admin
We completed the investment of 2 new companies during the summer, Neural Dynamics Technologies and InMapz. The following is a brief introduction of them. Neural Dynamics Technologies, NDT for short, (https://neuraldynamicstechnologies.com/) was founded by a research scientist and a post doc at MIT who specialized in deep brain stimulation (DBS) researches. They are developing high-precision
We have made an investment in Superbio.ai Inc., a start up company that is in the process building a biomedical R&D AI/ML platform. The company’s aim is to build a No-code Auto machine learning platform for Biomedical and life science R&D. Although still in its early stage, it has already built a beta version of
Dear Investors, 2021 turned out to be quite a challenging year for everyone and all businesses. It was especially true for the start ups. The work-from-home and persistent threat of corona virus created a very difficult environment for small start ups to operate and to thrive. This has a direct impact on our investments. We
Our fund have invested in Advanced Silicon Group (ASG). The Company develops advanced biosensors for biopharmaceutical companies using silicon Nanowire photoelectric technology. The use of nanowire creates a high surface to volume ratio, which makes the sensors more sensitive to low proteins. Furthermore, the sensor allows rapid testing at a low cost. The same test
Our fund has made a small investment in Conversifi. Conversifi developed a multi-sided platform that connects language learners with native speakers for on-demand conversations over video chat. We first investigated the company in February of this year. Due to the Covid-19 pandemic, we suspended the due diligence in late March. Then back in September, we restarted the
Our fund have invested in a Life Science Tools company, S2 Genomics. S2 Genomics is a Life Science tools company. The company has developed SingulatorTM using patented technology to automates preparation of single cell and nuclei suspensions from solid tissues on cartridges. The product has just been commercially released. With many back orders from various industrial clients, the company
Investment in a Life Science Tools company, S2 GenomicsRead More »
The fund has invested in SharingOS, a company specialized in Micromobility (move within 0-5 miles) market. In the global micromobility market, almost all the vehicles are powered by batteries. SharingOS has developed a smart battery optimization software platform and distributed smart swappable batteries. The benefits of the swappable battery design by SharingOS allows vehicle operating
After a few months hibernation due to covid-19 pandemic, your fund managers were back to work in June, starting looking for next startups to invest. Following two months of analyzing many companies and performing due diligence on a couple of promising ones, we have made investment to CRISP-HP Therapeutics, Inc., a generic engineering company, focusing
Investment to CRISP-HR Therapeutics, Inc. is CompletedRead More »
Although the fund has temporarily suspended any new investment activities since March, 2020 due to COVID-19 pandemic, your fund managers have been working diligently to manage our existing portfolio, keeping frequent contacts with the companies our fund have invested in. As expected, the COVID-19 has affected the operations of almost all our invested companies. However,